No active 13F manager changed its position in CYPHERPUNK TECHNOLOGIES INC. last quarter. Over the last 180 days, 2 insiders sold and none bought, a net -$77K in open-market trades.
The legs disagree, or only one of them leans.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Dietz Thomas John | Director | Sell (S) | 20K | $34K |
| Mar 26, 2026 | Mirabelli Christopher | Director | Sell (S) | 60K | $43K |
| Nov 17, 2025 | Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec., Director | Sell (S) 2 lots, same day | 676K | $2.1M |
| Nov 17, 2025 | Cavanaugh James H | Director | Sell (S) | 262K | $822K |
| Nov 17, 2025 | Mirabelli Christopher | Director | Sell (S) 2 lots, same day | 676K | $2.1M |
| Sep 24, 2021 | BeiGene, Ltd. | 10% Owner | Buy (P) | 2.5M | $7.2M |
| Jun 22, 2020 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Buy (P) | 1.8M | $3.5M |
| Feb 5, 2019 | Mirabelli Christopher | CEO, President, Chairman, Director, 10% Owner | Buy (P) | 571K | $1000K |
| Feb 5, 2019 | Lawlor Augustine | Chief Operating Officer, 10% Owner | Buy (P) | 571K | $1000K |
| Feb 5, 2019 | Onsi Douglas E | CFO, GC, Treasurer & Secretary, 10% Owner | Buy (P) | 571K | $1000K |
| Feb 5, 2019 | HealthCare Ventures IX, L.P. | 10% Owner | Buy (P) | 571K | $1000K |
| Nov 14, 2017 | Lawlor Augustine | Chief Operating Officer, 10% Owner | Buy (P) | 1.1M | $6.4M |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 2 | -$77K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for CYPHERPUNK TECHNOLOGIES INC.
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/LPTX/capital-change-brief"
Use Arkolith's capital_change_brief for CYPHERPUNK TECHNOLOGIES INC.. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for LPTX. Filings are public domain, sourced to SEC EDGAR.